α-Artemether

Artemether for severe malaria

BACKGROUND In 2011 the World Health Organization (WHO) recommended parenteral artesunate in preference to quinine as first-line treatment for people with severe malaria. Prior to this recommendation, many countries, particularly in Africa, had begun to use artemether, an alternative artemisinin derivative. This review evaluates intramuscular artemether compared with both quinine and artesunate....

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis.

Most prescribers and patients in Ghana now opt for the relatively expensive artemether/lumefantrine rather than artesunate-amodiaquine due to undesirable side effects in the treatment of uncomplicated malaria. The study sought to determine the existence of substandard and/or counterfeit artemether-lumefantrine tablets and suspension as well as artemether injection on the market in Cape Coast. S...

Preformulation Studies of Artemether, Quinine and Artemether-Lumefantrine Intended for Fixed-Dose Suppository Formulations

Supporting Information Potential sonodynamic anticancer activities of artemether and the liposome–encapsulated artemether

[ † ] These authors contributed equally to this work.

Case Report of a Pituitary Macroadenoma Treated With Artemether Artemether and Pituitary Macroadenoma

with radiation) is the most common treatment option. Treatment of adenomas with surgery alone is associated with a 9% risk of significant complications other than hypothyroidism. Additionally, there is a significant recurrence risk with surgical treatment alone. Park et al found a 5-year recurrence rate of 15.2% and a 10-year recurrence rate of 50.5% for 132 patients having nonfunctioning macro...